Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0F0AU
|
|||
| Former ID |
DNC006009
|
|||
| Drug Name |
3-methyl-1H-thieno[2,3-c]pyrazole-5-carboxamide
|
|||
| Synonyms |
CHEMBL198022; 3-methyl-1H-thieno[2,3-c]pyrazole-5-carboxamide; SCHEMBL15514276
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C7H7N3OS
|
|||
| Canonical SMILES |
CC1=C2C=C(SC2=NN1)C(=O)N
|
|||
| InChI |
1S/C7H7N3OS/c1-3-4-2-5(6(8)11)12-7(4)10-9-3/h2H,1H3,(H2,8,11)(H,9,10)
|
|||
| InChIKey |
MELHJKUYOBXOER-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Scaffold oriented synthesis. Part 1: Design, preparation, and biological evaluation of thienopyrazoles as kinase inhibitors. Bioorg Med Chem Lett. 2006 Jan 1;16(1):96-9. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.